– Teralys Capital, Canada’s largest and sole independent innovation-focused institutional investor, announced an additional $475 million in commitments.
– This commitment is the largest-ever fund of funds awarded under the Government of Canada‘s Venture Capital Catalyst Initiative (VCCI), in collaboration with the Government of Québec.
– Teralys is supported by a prestigious network of local and international private investors, including:
– Leading institutional investors like Caisse de dépôt et placement du Québec (CDPQ), Beneva, Fondaction, and Bpifrance.
– Innovation-focused universities such as Concordia University, Polytechnique Montréal, and AGIR HECMontréal.
– Several successful Canadian entrepreneurs and family offices.
– Teralys Capital focuses on supporting technology funds and companies in key innovation sectors, such as:
– Information technology
– Life sciences
– Clean and industrial innovations
– The company’s mission is to help entrepreneurs grow their businesses into anchor companies in fields crucial to Canada’s new economy, such as:
– Artificial intelligence
– Precision medical therapies
– Teralys Capital has a 15-year history of leadership in Canada’s venture capital and life sciences sector, including:
– Launching new programs for emerging managers in Quebec.
– Building partnerships with investors and strategic allies across North America and Europe.
– Jacques Bernier, Managing Partner of Teralys Capital, highlighted the firm’s sustained growth and support for exceptional entrepreneurs over 15 years.
– Teralys Capital manages over $2.5 billion in assets across 5 specialized venture capital fund-of-funds, making it the largest innovation-focused investor in Canada.
– The firm finances private venture capital funds that invest across the full spectrum of growth stages, from early start-ups to expansion and technology buy-outs.
– Teralys is proud to support the Kauffman Fellows Global Summit, which was held for the first time in Montreal.
